Sign in
Taking people in United StatesNo phase

Genetics of Appendix Cancer Study

Key facts

Who runs it
Andreana Holowatyj, PhD, MSCI
Where
Nashville, United StatesSee the site
Trial code
Status
Recruiting
People taking part
700 people, planned
Started
11 Nov 2022
Expected to end
Nov 2034
Type of study
Observational, 3 groups
Treatments tested
  • Genetic profiling
  • Retrospective tissue procurement
Record updated
18 April 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • GAP Social
  • Known diagnosis of appendix cancer in the United States
  • Mentally and physically able to consent and participate in the study; GAP Vanderbilt
  • Known diagnosis of appendix cancer
  • Diagnosed by and/or consulting with a physician/clinical provider participating in the GAP Study
  • Mentally and physically able to consent and participate in the study; GAP Parent
  • Biological parents (mother and/or father) of individuals actively participating in the GAP Study
  • Residing in the United States
  • Mentally and physically able to consent and participate in the study

Who cannot take part

  • Women pregnant at the time of consent
  • Prisoners
  • Unable to provide informed consent
  • Unable to read, write, or complete questionnaires in English

This trial is currently available in United States.

  • Vanderbilt-Ingram Cancer CenterNashville, United StatesContact: GAP Study Coordinator (Rebecca B.)Taking people

About the trial

What the trial wants to find out

The GAP Study is a prospective cohort study designed to comprehensively investigate genetic variations that may contribute to cancer development among individuals diagnosed with appendix/appendiceal cancer who are ages 18+ years.

The 3 groups in the trial

  • GAP Social

    Individuals ages 18+ years with an appendix cancer diagnosis in the United States.

    Treatment: Genetic profiling and Retrospective tissue procurement

  • GAP Vanderbilt

    Individuals ages 18+ years with an appendix cancer diagnosis seen at Vanderbilt.

    Treatment: Genetic profiling and Retrospective tissue procurement

  • GAP Parent

    Biological parents of active GAP (Social and Vanderbilt) Study participants.

    Treatment: Genetic profiling

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Genetics of Appendix Cancer: The GAP Study
Record updated
18 April 2025